Recap from Bloom Burton & Co. Healthcare Investor Conference
A few weeks ago, Toronto Stock Exchange (TSX) was proud to be involved in the annual Bloom Burton Healthcare Investor Conference. This event brings hundreds of investors and companies together to learn about the latest trends across the sector, including biotechnology, medical technology, and digital health. The conference has grown tremendously over the years, with a record number of investors this year, highlighting the growing surge and interest in the Canadian ecosystem. At the conference, 25 companies listed on TSX and TSX Venture Exchange (TSXV) presented to investors. Below is more information on those companies, and links to their investor relations websites to learn more about them.
(TSXV:RX)?
BioSyent is a pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients.?
(TSX:CRRX)?
CareRx is a leading provider of pharmacy services to seniors living communities, serving? approximately 94,000 residents in over 1,500 seniors and other congregate care communities (long-term care homes, retirement homes, assisted living facilities, and group homes) in Canada.?
(TSX:CPH)
Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and “active ingredients” from oats and other renewable plant resources.?
(TSX:CPH)?
Cipher Pharmaceuticals is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America.
(TSX:DNTL)?
dentalcorp is Canada's largest and one of North America's fastest growing networks of dental practices, committed to advancing the overall well-being of Canadians by delivering the best clinical outcomes and unforgettable experiences. dentalcorp acquires leading dental practices, uniting its network in a common goal: to be Canada's most trusted healthcare network.?
(TSX:DHT.UN/DHT.U) DRI Healthcare Trust is managed by DRI Capital Inc. (“DRI Capital”), the pioneer in global pharmaceutical royalty monetization with a more than 30-year history of accelerating innovation by providing capital to inventors, academic institutions and biopharma companies. Since its founding in 1989, DRI Capital has deployed more than US$3.0 billion, acquiring more than 70 royalties on 45-plus drugs, including Eylea, Keytruda, Orserdu, Spinraza, Stelara, Vonjo, Zejula and Zytiga.
(TSX:EPRX)?
Eupraxia Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need.?
(TSXV:WOLF)?
Grey Wolf Animal Health Corp. is a diversified animal health company founded by a veterinarian to bring to market a broad portfolio of products that meets the unmet needs of veterinarians, clinics and pets.?
(TSX:HTL) Hamilton Thorne is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART), research, and cell biology markets.?
(TSX:AIDX)?
HEALWELL AI is a healthcare technology company focused on AI and data science for preventative care. Its mission is to improve health care and save lives through early identification and detection of disease.?
(TSX:HLS)?
Formed in 2015, HLS is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets.
(TSX:GUD)
Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. Knight's Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM
(TSXV:LSL)
LSL Pharma Group is an integrated Canadian pharmaceutical company specializing in the development, manufacture, and commercialization of high-quality sterile ophthalmic pharmaceuticals for the Canadian, US and global markets. The Corporation also manufactures under contract (CDMO), a full suite of solid-dose products, such as tablets, capsules, bags and others.
领英推荐
(TSX:MDP)
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus's current focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.
(TSX:MDNA)
Medicenna is a clinical-stage immunotherapy company focused on developing novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first-in-class empowered superkines.
(TSX:MBX)
Microbix Biosystems Inc. creates proprietary biological products for human health. It makes a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs?) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows.?
(TSXV:NPTH)
NeuPath operates a network of healthcare clinics and related businesses focused on improved access to care and outcomes for patients by leveraging best-in-class treatments and delivering patient-centered multidisciplinary care.?
(TSXV:NEWU)
Newtopia is a tech-enabled habit change provider focused on disease prevention and reducing the cost of care for health insurers.?
(TSX:PRN)
Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue.?
(TSX:MSCL)
Satellos is a publicly traded biotechnology company dedicated to developing life-improving medicines to treat degenerative muscle diseases. Satellos has incorporated breakthrough research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenXTM, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention.?
(TSX:SVA)
Sernova is a clinical-stage biotechnology company that is advancing a novel cell therapy platform for the treatment of chronic diseases. Our lead program is evaluating our Cell Pouch System? as a potential ‘functional cure’ for insulin dependent diabetes. In addition, we have a robust pipeline that includes preclinical programs in hemophilia A and hypothyroidism.
(TSX:TH)
Theratechnologies is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs.
(TSX:VPH)
Valeo Pharma is a fast-growing Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respiratory/Allergy, Ophthalmology and Hospital Specialty Products. Headquartered in Kirkland, Quebec Valeo Pharma has all the required capabilities and the full infrastructure to register and properly manage its growing product portfolio through all stages of commercialization.
(TSX:VHI)
Software for Health and Human Services providers designed to simplify the user experience and optimize outcomes. VitalHub Corp. provides technology to Health and Human Services providers including Hospitals, Regional Health Authorities, Mental Health, Long Term Care, Home Health, Community and Social Services. VitalHub solutions span the categories of Electronic Health Record (EHR), Case Management, Care Coordination & Optimization, and Patient Flow & Operational Visibility solutions.?
(TSX:WELL)?
WELL’s mission is to tech-enable healthcare providers, by developing leading technologies, services, and support, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL’s comprehensive healthcare and digital platform includes extensive front and backoffice management software applications that help physicians run and secure their practices.?